LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 78.15 | 21.74 | 4116 | 6167 | 0.6674 | 0.9032 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 78.15 | 21.74 | 4147 | 6167 | 0.6724 | 0.9049 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 78.15 | 21.74 | 4625 | 6167 | 0.7499 | 0.9306 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 78.15 | 21.74 | 5534 | 6167 | 0.8973 | 0.9736 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 78.15 | 21.74 | 4316 | 6167 | 0.6998 | 0.9143 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 78.15 | 21.74 | 4345 | 6167 | 0.7045 | 0.9158 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 80.12 | 21.74 | 4322 | 6211 | 0.6958 | 0.9130 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 80.12 | 21.74 | 4353 | 6211 | 0.7008 | 0.9147 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 80.12 | 21.74 | 4940 | 6211 | 0.7953 | 0.9446 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 80.12 | 21.74 | 5777 | 6211 | 0.9300 | 0.9823 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 80.12 | 21.74 | 4534 | 6211 | 0.7299 | 0.9243 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 80.12 | 21.74 | 4569 | 6211 | 0.7355 | 0.9261 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 82.09 | 21.74 | 4549 | 6201 | 0.7336 | 0.9255 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 82.09 | 21.74 | 4576 | 6201 | 0.7379 | 0.9268 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 82.09 | 21.74 | 5119 | 6201 | 0.8255 | 0.9535 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 82.09 | 21.74 | 5948 | 6201 | 0.9592 | 0.9898 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 82.09 | 21.74 | 4795 | 6201 | 0.7732 | 0.9379 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 82.09 | 21.74 | 4834 | 6201 | 0.7795 | 0.9398 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.06 | 21.74 | 4712 | 6152 | 0.7659 | 0.9356 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.06 | 21.74 | 4748 | 6152 | 0.7718 | 0.9374 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.06 | 21.74 | 5515 | 6152 | 0.8964 | 0.9733 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.06 | 21.74 | 6205 | 6152 | 1.0086 | 1.0021 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.06 | 21.74 | 5028 | 6152 | 0.8173 | 0.9511 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.06 | 21.74 | 5060 | 6152 | 0.8225 | 0.9526 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 86.03 | 21.74 | 5024 | 6155 | 0.8162 | 0.9508 | MN20160310_N01 | D18 |